Dhiraj Baruah MD, Presenter: Nothing to Disclose

Kaushik S. Shahir MD, Abstract Co-Author: Nothing to Disclose

Rahul N. Sawlani MD, Abstract Co-Author: Nothing to Disclose

Zachary R. Laste MD, Abstract Co-Author: Nothing to Disclose

Vijay Ramalingam MD, Abstract Co-Author: Nothing to Disclose

Kavita Joshi MD, Abstract Co-Author: Nothing to Disclose

Amit Taneja MD, Abstract Co-Author: Nothing to Disclose

Nagarjun Rao, Abstract Co-Author: Nothing to Disclose

Lawrence R. Goodman MD, Abstract Co-Author: Nothing to Disclose

Pulmonary toxicity of many established drugs have been described in the literature along with their imaging appearances (like amiodarone, busulfun, lidocaine etc). However, we have encountered changes with several newer drugs (bortezomib, cimzia, voriconazole, remicaide etc.), which are not well described. These changes are very important to understand for proper patient care. Aim of our exhibit is to present examples of pulmonary changes related to some of the newer drugs and their pathophysiologic mechanism. This review will help radiologists understand these changes and keep them in differential consideration in proper clinical situations.

a. Overview of pathophysiology of pulmonary changes related to newer drugs. b. Correlating those changes in imaging with case examples

http://abstract.rsna.org/uploads/2014/14008217/14008217_2vky.pdf

Baruah, D, Shahir, K, Sawlani, R, Laste, Z, Ramalingam, V, Joshi, K, Taneja, A, Rao, N, Goodman, L, Know How your Lungs Behave with Newer Drugs—Imaging Appearances of Lung Toxicity Related to Recently Marketed Drugs.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14008217.html